Dual Regulatory Roles of Human AP-Endonuclease (APE1/Ref-1) in CDKN1A/p21 Expression

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Sengupta, Shiladitya ^a   Mitra, Sankar ^a,b   Bhakat, Kishor K ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; PROTEIN P21; PROTEIN P53;

ARTICLE; BINDING SITE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME REGULATION; ENZYME REPRESSION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY;

BINDING SITES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; HCT116 CELLS; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880486045     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068467     Document Type: Article

References (69)

1. Demple B, Harrison L, Wilson DM 3rd, Bennett RA, Takagi T, et al (1997) Regulation of eukaryotic abasic endonucleases and their role in genetic stability. Environmental health perspectives 105Suppl 4: 931-934.
2. Doetsch PW, Cunningham RP, (1990) The enzymology of apurinic/apyrimidinic endonucleases. Mutat Res 236: 173-201.
3. Izumi T, Wiederhold LR, Roy G, Roy R, Jaiswal A, et al. (2003) Mammalian DNA base excision repair proteins: their interactions and role in repair of oxidative DNA damage. Toxicology 193: 43-65.
4. Daviet S, Couve-Privat S, Gros L, Shinozuka K, Ide H, et al. (2007) Major oxidative products of cytosine are substrates for the nucleotide incision repair pathway. DNA repair 6: 8-18.
5. Gros L, Ishchenko AA, Ide H, Elder RH, Saparbaev MK, (2004) The major human AP endonuclease (Ape1) is involved in the nucleotide incision repair pathway. Nucleic acids research 32: 73-81.
6. Bapat A, Fishel ML, Kelley MR, (2009) Going ape as an approach to cancer therapeutics. Antioxid Redox Signal 11: 651-668.
7. Bhakat KK, Mantha AK, Mitra S, (2009) Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein. Antioxidants & redox signaling 11: 621-638.
8. Evans AR, Limp-Foster M, Kelley MR, (2000) Going APE over ref-1. Mutat Res 461: 83-108.
9. Tell G, Quadrifoglio F, Tiribelli C, Kelley MR, (2009) The Many Functions of APE1/Ref-1: Not Only a DNA Repair Enzyme. Antioxid Redox Signal 11: 601-620.
10. Okazaki T, Chung U, Nishishita T, Ebisu S, Usuda S, et al. (1994) A redox factor protein, ref1, is involved in negative gene regulation by extracellular calcium. J Biol Chem 269: 27855-27862.
11. Fuchs S, Philippe J, Corvol P, Pinet F, (2003) Implication of Ref-1 in the repression of renin gene transcription by intracellular calcium. J Hypertens 21: 327-335.
12. Sengupta S, Chattopadhyay R, Mantha AK, Mitra S, Bhakat KK, (2012) Regulation of mouse-renin gene by apurinic/apyrimidinic-endonuclease 1 (APE1/Ref-1) via recruitment of histone deacetylase 1 corepressor complex. Journal of hypertension 30: 917-925.
13. Bhakat KK, Izumi T, Yang SH, Hazra TK, Mitra S, (2003) Role of acetylated human AP-endonuclease (APE1/Ref-1) in regulation of the parathyroid hormone gene. Embo J 22: 6299-6309.
14. Yamamori T, DeRicco J, Naqvi A, Hoffman TA, Mattagajasingh I, et al. (2010) SIRT1 deacetylates APE1 and regulates cellular base excision repair. Nucleic acids research 38: 832-845.
15. Bhattacharyya A, Chattopadhyay R, Burnette BR, Cross JV, Mitra S, et al. (2009) Acetylation of apurinic/apyrimidinic endonuclease-1 regulates Helicobacter pylori-mediated gastric epithelial cell apoptosis. Gastroenterology 136: 2258-2269.
16. Fantini D, Vascotto C, Deganuto M, Bivi N, Gustincich S, et al. (2008) APE1/Ref-1 regulates PTEN expression mediated by Egr-1. Free Radic Res 42: 20-29.
17. Ray S, Lee C, Hou T, Bhakat KK, Brasier AR, (2010) Regulation of signal transducer and activator of transcription 3 enhanceosome formation by apurinic/apyrimidinic endonuclease 1 in hepatic acute phase response. Mol Endocrinol 24: 391-401.
18. Xanthoudakis S, Smeyne RJ, Wallace JD, Curran T, (1996) The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proc Natl Acad Sci U S A 93: 8919-8923.
19. Meira LB, Devaraj S, Kisby GE, Burns DK, Daniel RL, et al. (2001) Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress. Cancer Res 61: 5552-5557.
20. Izumi T, Brown DB, Naidu CV, Bhakat KK, Macinnes MA, et al. (2005) Two essential but distinct functions of the mammalian abasic endonuclease. Proc Natl Acad Sci U S A 102: 5739-5743.
21. Busso CS, Iwakuma T, Izumi T, (2009) Ubiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway. Oncogene 28: 1616-1625.
22. Huang E, Qu D, Zhang Y, Venderova K, Haque ME, et al. (2010) The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death. Nature cell biology 12: 563-571.
23. Busso CS, Wedgeworth CM, Izumi T, (2011) Ubiquitination of human AP-endonuclease 1 (APE1) enhanced by T233E substitution and by CDK5. Nucleic acids research 39: 8017-8028.
24. Kelley MR, Cheng L, Foster R, Tritt R, Jiang J, et al. (2001) Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res 7: 824-830.
25. Robertson KA, Bullock HA, Xu Y, Tritt R, Zimmerman E, et al. (2001) Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation. Cancer Res 61: 2220-2225.
26. Xu Y, Moore DH, Broshears J, Liu L, Wilson TM, et al. (1997) The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer. Anticancer Res 17: 3713-3719.
27. Chattopadhyay R, Das S, Maiti AK, Boldogh I, Xie J, et al. (2008) Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1. Mol Cell Biol 28: 7066-7080.
28. Fishel ML, Kelley MR, (2007) The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Mol Aspects Med 28: 375-395.
29. Jiang Y, Guo C, Fishel ML, Wang ZY, Vasko MR, et al. (2009) Role of APE1 in differentiated neuroblastoma SH-SY5Y cells in response to oxidative stress: use of APE1 small molecule inhibitors to delineate APE1 functions. DNA Repair (Amst) 8: 1273-1282.
30. Jiang Y, Guo C, Vasko MR, Kelley MR, (2008) Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. Cancer Res 68: 6425-6434.
31. McNeill DR, Lam W, DeWeese TL, Cheng YC, Wilson DM 3rd (2009) Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites. Mol Cancer Res 7: 897-906.
32. Robertson KA, Hill DP, Xu Y, Liu L, Van Epps S, et al. (1997) Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells. Cell Growth Differ 8: 443-449.
33. Wang D, Luo M, Kelley MR, (2004) Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther 3: 679-686.
34. Sengupta S, Mantha AK, Mitra S, Bhakat KK, (2011) Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. Oncogene 30: 482-493.
35. Meek DW, (2009) Tumour suppression by p53: a role for the DNA damage response? Nature reviews Cancer 9: 714-723.
36. Jiang L, Sheikh MS, Huang Y, (2010) Decision Making by p53: Life versus Death. Molecular and cellular pharmacology 2: 69-77.
37. Abbas T, Dutta A, (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400-414.
38. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
39. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, et al. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501.
40. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S, et al. (1997) Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev 11: 558-570.
41. Gaiddon C, Moorthy NC, Prives C, (1999) Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. Embo J 18: 5609-5621.
42. Vascotto C, Cesaratto L, Zeef LA, Deganuto M, D'Ambrosio C, et al. (2009) Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. Proteomics 9: 1058-1074.
43. Jiang Y, Zhou S, Sandusky GE, Kelley MR, Fishel ML, (2010) Reduced expression of DNA repair and redox signaling protein APE1/Ref-1 impairs human pancreatic cancer cell survival, proliferation, and cell cycle progression. Cancer investigation 28: 885-895.
44. Bhakat KK, Hazra TK, Mitra S, (2004) Acetylation of the human DNA glycosylase NEIL2 and inhibition of its activity. Nucleic Acids Res 32: 3033-3039.
45. Das S, Chattopadhyay R, Bhakat KK, Boldogh I, Kohno K, et al. (2007) Stimulation of NEIL2-mediated oxidized base excision repair via YB-1 interaction during oxidative stress. J Biol Chem 282: 28474-28484.
46. Ramana CV, Boldogh I, Izumi T, Mitra S, (1998) Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc Natl Acad Sci U S A 95: 5061-5066.
47. Nowak DE, Tian B, Brasier AR, (2005) Two-step cross-linking method for identification of NF-kappaB gene network by chromatin immunoprecipitation. BioTechniques 39: 715-725.
48. Schonn I, Hennesen J, Dartsch DC, (2010) Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damage. Apoptosis: an international journal on programmed cell death 15: 162-172.
49. Gartel AL, Tyner AL, (1999) Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res 246: 280-289.
50. Jung P, Menssen A, Mayr D, Hermeking H, (2008) AP4 encodes a c-MYC-inducible repressor of p21. Proc Natl Acad Sci U S A 105: 15046-15051.
51. Jung P, Hermeking H, (2009) The c-MYC-AP4-p21 cascade. Cell cycle 8: 982-989.
52. Ku WC, Chiu SK, Chen YJ, Huang HH, Wu WG, (2009) Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2. Molecular & cellular proteomics: MCP 8: 2034-2050.
53. Agarwal ML, Agarwal A, Taylor WR, Stark GR, (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 92: 8493-8497.
54. Niculescu AB 3rd, Chen X, Smeets M, Hengst L, Prives C, et al (1998) Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Molecular and cellular biology 18: 629-643.
55. Chen J, Jackson PK, Kirschner MW, Dutta A, (1995) Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374: 386-388.
56. Abukhdeir AM, Park BH, (2008) P21 and p27: roles in carcinogenesis and drug resistance. Expert reviews in molecular medicine 10: e19.
57. Abukhdeir AM, Vitolo MI, Argani P, De Marzo AM, Karakas B, et al. (2008) Tamoxifen-stimulated growth of breast cancer due to p21 loss. Proceedings of the National Academy of Sciences of the United States of America 105: 288-293.
58. el-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, et al. (1995) Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 55: 2910-2919.
59. Strauss PR, Holt CM, (1998) Domain mapping of human apurinic/apyrimidinic endonuclease. Structural and functional evidence for a disordered amino terminus and a tight globular carboxyl domain. J Biol Chem 273: 14435-14441.
60. Vidal AE, Boiteux S, Hickson ID, Radicella JP, (2001) XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. Embo J 20: 6530-6539.
61. Vascotto C, Fantini D, Romanello M, Cesaratto L, Deganuto M, et al. (2009) APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in the rRNA quality control process. Mol Cell Biol 29: 1834-1854.
62. Mohiuddin M, Chendil D, Dey S, Alcock RA, Regine W, et al. (2002) Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells. Anticancer research 22: 825-830.
63. Fishel ML, He Y, Reed AM, Chin-Sinex H, Hutchins GD, et al. (2008) Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth. DNA Repair (Amst) 7: 177-186.
64. Zaky A, Busso C, Izumi T, Chattopadhyay R, Bassiouny A, et al. (2008) Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage. Nucleic Acids Res.
65. Xinghua L, Bo Z, Yan G, Lei W, Changyao W, et al. (2012) The overexpression of AP-4 as a prognostic indicator for gastric carcinoma. Medical oncology 29: 871-877.
66. Cao J, Tang M, Li WL, Xie J, Du H, et al. (2009) Upregulation of activator protein-4 in human colorectal cancer with metastasis. International journal of surgical pathology 17: 16-21.
67. Liu X, Zhang B, Guo Y, Liang Q, Wu C, et al. (2012) Down-regulation of AP-4 inhibits proliferation, induces cell cycle arrest and promotes apoptosis in human gastric cancer cells. PloS one 7: e37096.
68. Zou GM, Karikari C, Kabe Y, Handa H, Anders RA, et al. (2009) The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis. Journal of cellular physiology 219: 209-218.
69. Zou GM, Maitra A, (2008) Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration. Molecular cancer therapeutics 7: 2012-2021.